Screening for gynecologic malignancies: A continuing responsibility. (Q33714900)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10452936%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

review article

1 reference

title

Screening for gynecologic malignancies: A continuing responsibility (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10452936%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

author name string

Runowicz CD

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10452936%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

Fields AL

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10452936%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10452936%20AND%20SRC:MED&resulttype=core&format=json

Surgical oncology clinics of North America

11 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10452936%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10452936%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10452936%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

page(s)

703-23, vii

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10452936%20AND%20SRC:MED&resulttype=core&format=json

Endometrial morphology in asymptomatic postmenopausal women

11 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

High Frequency of BRCA1 and BRCA2 Germline Mutations in Ashkenazi Jewish Ovarian Cancer Patients, Regardless of Family History

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Ultrasound screening for familial ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Inadequacy of papanicolaou smears in the detection of endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

The reduction in risk of ovarian cancer associated with oral-contraceptive use

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Oral contraceptive use and the risk of endometrial cancer. The Centers for Disease Control Cancer and Steroid Hormone Study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

The genetic attributable risk of breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Improved Accuracy for Cervical Cytology with the ThinPrep Method and the Endocervical Brush-Spatula Collection Procedure.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Over-the-counter analgesics and risk of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Screening in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

To err is human--to sue, American

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Can fenretinide protect women against ovarian cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

What do we know and what don't we know about tamoxifen in the human uterus

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Use of progestogen therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Mass screening for endometrial cancer directed in risk groups of patients with diabetes and patients with hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Tubal ligation, hysterectomy, and risk of ovarian cancer. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Screening and genetic counselling for relatives of patients with colorectal cancer in a family cancer clinic

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Genetic, biochemical, and multimodal approaches to screening for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Prevalence screening for ovarian cancer in postmenopausal women by CA 125 measurement and ultrasonography

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

The screening histories of women with invasive cervical cancer, Connecticut

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Transvaginal ultrasonography of the endometrium in women with postmenopausal bleeding — a Nordic multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Treatment and follow-up strategies in hereditary nonpolyposis colorectal carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Tumor spectrum in cancer family syndrome (hereditary nonpolyposis colorectal cancer)

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

The efficacy and safety of the cytobrush during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Evaluation of the ThinPrep Pap test in clinical practice. A seven-month, 16,314-case experience in northern Vermont

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Automated slide preparation system for the clinical laboratory

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Malpractice protection: communication of diagnostic uncertainty

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Progesterone challenge test and estrogen assays in menopausal women with endometrial adenomatous hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Ovarian cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

The Papanicolaou smear histories of 237 patients with cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

Extracolonic cancer in hereditary nonpolyposis colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

The validity of Pap smear parameters as predictors of endometrial pathology in menopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS1055-3207%2818%2930184-4

7 January 2021

10.1016/S1055-3207(18)30184-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10452936%20AND%20SRC:MED&resulttype=core&format=json

11 December 2019

1 reference